Related Experiment Video
Updated: Aug 22, 2025
12:58
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
9.1K
Clostridium difficile colitis and peritoneal dialysis associated peritonitis: 'Difficile' treatment considerations
Anna Giuliani1,2, Silvia Lerco2,3, Sabrina Milan Manani1,2
1Department of Nephrology Dialysis and Transplantation, San Bortolo Hospital, Vicenza, Italy.
Summary
Peritonitis in peritoneal dialysis (PD) patients can be complicated by Clostridium difficile infection (CDI). Managing this dual diagnosis requires careful antibiotic selection to avoid worsening either condition.
Area of Science:
- Nephrology
- Infectious Diseases
- Gastroenterology
Background:
- Peritoneal dialysis (PD) peritonitis is a major cause of treatment failure.
- Clostridium difficile infection (CDI) is common in end-stage kidney disease patients, causing significant morbidity.
- Current guidelines lack strategies for managing PD peritonitis concurrently with CDI.
Observation:
- A case of culture-negative PD-associated peritonitis with concurrent CDI is presented.
- The patient exhibited typical CDI symptoms of diarrhea alongside peritonitis indicators like abdominal pain and cloudy effluent.
- This dual diagnosis presents a complex treatment challenge.
Findings:
- Broad-spectrum antibiotics for peritonitis may exacerbate CDI.
- Inadequate antibiotic treatment for peritonitis can lead to worsening infection.
- The interplay between PD peritonitis and CDI necessitates a nuanced therapeutic approach.
Implications:
- There is a critical need for updated clinical guidelines addressing PD peritonitis in CDI patients.
- Developing specific treatment protocols is essential for optimizing patient outcomes.
- Further research is required to understand and manage this complex clinical scenario effectively.
Related Concept Videos
01:25Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
78
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
78
01:25Peritoneal Dialysis III: Nursing Management
100
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
100
01:30Peritoneal Dialysis I: Introduction and Procedure
123
Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
123
01:29Drugs for Treatment of Ulcerative Colitis in IBD
223
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
223
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
248
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
248
01:17Drugs for Treatment of Diarrhea-Predominant IBS
266
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
266